MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.410
+0.070 (5.22%)
At close: Oct 9, 2026, 4:00 PM EDT
1.400
-0.010 (-0.71%)
After-hours: Oct 9, 2026, 7:30 PM EDT
MetaVia Market Cap
MetaVia has a market cap or net worth of $9.29 million as of October 9, 2026. It is the 42,077th most valuable company in the world and the 5,697th biggest in the United States. Its market cap has decreased by 64.45% in one year.
Market Cap
9.29M
Enterprise Value
-3.17M
1-Year Change
-64.45%
Global Rank
Country Rank
#5,697 United States
Category
ChartMarket Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $9.29M, a decrease of -99.99%. That is a compound annual growth rate of -74.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 9.29M | -49.88% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 10.32M |
| Chemomab Therapeutics | 10.29M |
| Ensysce Biosciences | 10.27M |
| BioVie | 10.26M |
| Theriva Biologics | 10.20M |
| Purple Biotech | 10.17M |
| Immuron | 9.93M |
| Senti Biosciences Holdings | 9.84M |